Arcellx enters $24.5M manufacturing SOW with Lonza for CART-ddBCMA

Arcellx, Inc.

Statement of work effective Feb 16, 2022 for technology transfer and cGMP manufacturing of CART-ddBCMA and other pipeline products.
Total payments aggregating approximately $24.5 million in 2022, including creditable upfront and milestone payments.
Term from February 1, 2022 to December 31, 2024, unless earlier terminated or extended.
Non-cancellable for first six months; potential termination costs aggregate up to approximately $35 million.
Either party may terminate for uncured material breach; Company pays non-cancellable costs on breach.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.